Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Gyeongsang
Clinical trial register · South Korea

Clinical Trials in Gyeongsang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 2821 Daegu 554 Seongnam-si 493 Busan 468 Goyang-si 396
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul2821 Daegu554 Seongnam-si493 Busan468 Goyang-si396
All 252 locations
Target enrolment
to

Trials with a site in Gyeongsang

7 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
Ipsen
Observational
10
Gyeongsang, Seoul
2025-10-30
Active, closed
Pusan National University Yangsan Hospital
Not applicable
60
Gyeongsang
2024-02-21
Active, closed
Pusan National University Yangsan Hospital
Not applicable
30
Gyeongsang
2023-11-24
Not yet open
National Cancer Center, Korea
Not applicable
203
Busan, Gyeongsang, Seoul, Gyeonggi-do, Changwon
2023-08-17
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Busan, Daegu, Daejeon, Gangwon-do, Goyang-si, Gyeonggi-do, Gyeongsang, Seongnam-si
2022-08-03
Active, closed
Nuvation Bio Inc.
Phase 2
217
Busan, Gyeongsang, Hwasun, Seoul
2021-09-01
Active, closed
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
NCT04452591Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer
CG Oncology, Inc.
Phase 3
190
Goyang-si, Busan, Gyeongsang, Jeongnam, Seoul
2020-10-27
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/gyeongsang

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Gyeongsang.

How many clinical trials are recruiting in Gyeongsang?

1 of the 7 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gyeongsang), 7 studies
PhaseStudiesRecruitingShare
Not applicable3042.9%
Phase 32028.6%
Observational1114.3%
Phase 21014.3%

Most active sponsors

Lead sponsors with the most studies (Gyeongsang)
Lead sponsorStudiesRecruiting
Pusan National University Yangsan Hospital20
Bausch Health Americas, Inc.10
CG Oncology, Inc.10
Ipsen11
National Cancer Center, Korea10
Nuvation Bio Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.